CIK 0001829802
- Emerging growth company
Faeth Therapeutics, Inc.
Sign in to watch- Ticker
- FTH
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 512-200-2982
- Business address
- 701 TILLERY STREET #12 #1010, AUSTIN, TX, 78702
- Former names
- Sensei Biotherapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 12 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-02-15 | Celebi John President and CEO | Grant or award · Stock Option (Right to Buy) | +161,600 | 161,600 | ||
| 2022-02-14 | Cambrian BioPharma Inc 10% owner | Purchase | +10,000 | $4.18 | $42K | 5,185,786 |
| 2022-02-14 | Peyer James Director | Purchase | +10,000 | $4.18 | $42K | 5,185,786 |
| 2022-02-11 | Peyer James Director | Purchase | +12,500 | $4.40 | $55K | 5,175,786 |
| 2022-02-11 | Cambrian BioPharma Inc 10% owner | Purchase | +12,500 | $4.40 | $55K | 5,175,786 |
| 2022-02-10 | Peyer James Director | Purchase | +5,000 | $4.58 | $23K | 5,163,286 |
| 2022-02-10 | Cambrian BioPharma Inc 10% owner | Purchase | +5,000 | $4.58 | $23K | 5,163,286 |
| 2022-02-08 | Cambrian BioPharma Inc 10% owner | Purchase | +10,000 | $4.33 | $43K | 5,158,286 |
| 2022-02-08 | Peyer James Director | Purchase | +10,000 | $4.33 | $43K | 5,158,286 |
| 2022-02-04 | Cambrian BioPharma Inc 10% owner | Purchase | +2,500 | $4.45 | $11K | 5,148,286 |
| 2022-02-04 | Peyer James Director | Purchase | +2,500 | $4.45 | $11K | 5,148,286 |
| 2022-02-03 | Cambrian BioPharma Inc 10% owner | Purchase | +17,500 | $4.65 | $81K | 5,145,786 |
| 2022-02-03 | Peyer James Director | Purchase | +17,500 | $4.65 | $81K | 5,145,786 |
| 2022-01-28 | Cambrian BioPharma Inc 10% owner | Purchase | +8,900 | $4.22 | $38K | 5,128,286 |
| 2022-01-28 | Peyer James Director | Purchase | +8,900 | $4.22 | $38K | 5,128,286 |
| 2022-01-27 | Cambrian BioPharma Inc 10% owner | Purchase | +6,100 | $4.31 | $26K | 5,119,386 |
| 2022-01-27 | Peyer James Director | Purchase | +6,100 | $4.31 | $26K | 5,119,386 |
| 2022-01-26 | Peyer James Director | Purchase | +29,900 | $4.62 | $138K | 5,113,286 |
| 2022-01-26 | Cambrian BioPharma Inc 10% owner | Purchase | +29,900 | $4.62 | $138K | 5,113,286 |
| 2022-01-25 | Peyer James Director | Purchase | +20,100 | $4.86 | $98K | 5,083,386 |
Page 14 of 20 · 385 trades